BIIB Biogen Idec, Inc. Stock DD Sunday, March 30, 2014 8:24:34

New Post Public Reply Private Reply Replies (0) Message Board

Mar 30, 2014 at 9:24 PM

BIIB Biogen Idec, Inc. $BIIB Company Overview

Stock Message Board http://investorshangout.com/search?q=BIIB&...mp;yt1=Go!

Last Updated: Sunday, March 30, 2014 8:24:34 PM

Biogen Idec, Inc. BIIB Current Price and Quotes
Last Price 294.12
Previous Close 309.76 Open 305.01
Daily Range 314.19 - 292.67 52wk Range 358.89 - 186.36
Volume 2,555,334 Dividend N/A
Average Vol (3m) 1,588,417 Yield N/A
Biogen Idec, Inc. BIIB
Company Information

14 Cambridge Center
Cambridge, MA 02142

Website: http://www.idecpharm.com
Phone: (617) 679-2000

Biogen Idec, Inc. BIIB
Not Available

Biogen Idec, Inc. BIIB
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Dec 31, 2013 10-K
CIK 0000875045
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data

SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Notes

Formerly=IDEC Pharmaceuticals Corp. until 11-03
Note=6-97 State of Incorporation California changed to Delaware
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Biogen Idec, Inc. BIIB
BIIB Security Details

Share Structure

Market Value1 $78,538,437,096 a/o Mar 28, 2014
Shares Outstanding 236,212,930 a/o Oct 21, 2013
Float Not Available
Authorized Shares Not Available
Par Value 0.0005
Shareholders

Shareholders of Record 2,912 a/o Feb 14, 2008
Security Notes

New Issue=9-91 3,000,000 shs at $15 by Montgomery Securities et al.
Latest Addt'l Issue=11-00 2,600,000 shs at $181.81 by Merrill Lynch & Co. et al.
Cap. Change=shs increased by 2 for 1 split. Ex-date=12-21-99. Rec. date=12-01-99. Pay. date=12-20-99
Capital Change=shs increased by 3 for 1 split. Ex-date=01/18/2000. Rec date=12/26/2000. Pay date=01/17/2001.
Short Selling Data

Short Interest 12,521,397 (6.96%)
Nov 30, 2010
Significant Failures to Deliver No
Transfer Agent(s)

BNYMellon Shareowner Services

Biogen Idec, Inc. BIIB Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 6,932,199 5,516,461 5,048,634 4,716,423
Cost of Revenue 857,726 545,494 466,780 400,262
Gross Profit 6,074,473 4,970,967 4,581,854 4,316,161
Operating Expenses

Research and Development 1,444,053 1,334,919 1,219,602 1,248,604
Sales, General and Admin. 1,796,861 1,622,562 1,409,969 1,289,611
Non-Recurring Items - 2,225 19,026 320,129
Other 342,948 202,204 208,566 208,928
Operating Income 2,515,509 1,855,849 1,724,691 1,248,889
Income From Continuing Operations

Add'l Income/Expense Items (10,032) 46,048 (13,477) (18,983)
Earnings Before Interest and Tax 2,505,477 1,901,897 1,711,214 1,229,906
Interest Expense - - - -
Earnings Before Tax 2,505,477 1,901,897 1,711,214 1,229,906
Income Tax 601,014 470,554 444,528 331,333
Minority Interest - - 32,258 (106,700)
Equity Earnings Unconsolidated Subsidiary (17,224) (4,518) - -
Net Income Cont. Operations 1,887,239 1,426,825 1,234,428 1,005,273
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 1,862,341 1,380,033 1,234,428 1,005,273
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 1,862,341 1,380,033 1,234,428 1,005,273

Biogen Idec, Inc. BIIB Recent News

Mar 28, 2014 FDA Approves Biogen Idec's ALPROLIX(TM), the First Hemophilia B Therapy to Reduce Bleeding Episodes with Prophylactic Infusions Starting at Least a Week Apart
Mar 27, 2014 Critical Alerts For DirecTV, Biogen Idec, Time Warner, Isis Pharmaceuticals, and DreamWorks Animation Released By InvestorsObserver
Mar 26, 2014 Pharmaceutical Executive to Unveil Brand of the Year Award Recipients at iPharma 2014: CBI's Marketing Innovation Summit
Mar 26, 2014 Drug Approvals, Stock Price Movements, and New Tools for Standardization - Analyst Notes on Biogen Idec, Alexion, Actavis, Thermo Fisher Scientific, and Medtronic
Mar 24, 2014 Health Canada Approves Biogen Idec's Long-Acting ALPROLIX(TM) Therapy for Hemophilia B
Mar 20, 2014 AVEO Regains Worldwide Rights to AV-203
Mar 20, 2014 Stocks that Hit New 52-Week Highs -- Research on Biogen Idec, Intersil, QuickLogic and Microchip Technology
Mar 20, 2014 Biogen Idec to Present on Best Practices for Leveraging Quality and Regulatory Compliance Management Software on Apple iPads
Mar 20, 2014 Healthcare Companies Report FDA Approvals, Comprehensive Analysis, Schedules, and Stock Movements - Analyst Notes on Pfizer, Johnson & Johnson, Biogen, Express Scripts, and Forest Laboratories
Mar 19, 2014 George A. Scangos, Ph.D., of Biogen Idec to Join Agilent Technologies Board of Directors

1
2
3
4
5
next >

BIIB Biogen Idec, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=BIIB&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BIIB/quote
Stock Chart http://www.otcmarkets.com/stock/BIIB/chart
Company Info http://www.otcmarkets.com/stock/BIIB/company-info
Recent News http://www.otcmarkets.com/stock/BIIB/news
Financials http://www.otcmarkets.com/stock/BIIB/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BIIB/filings
Short Sales http://www.otcmarkets.com/stock/BIIB/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BIIB/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BIIB/research
Summary http://finance.yahoo.com/q?s=BIIB
Historical Prices http://finance.yahoo.com/q/hp?s=BIIB+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BIIB
Basic Chart http://finance.yahoo.com/q/bc?s=BIIB+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BIIB+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BIIB+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BIIB+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BIIB+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BIIB+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BIIB+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BIIB+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BIIB+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BIIB+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BIIB
Balance Sheet http://finance.yahoo.com/q/bs?s=BIIB
Cash Flow http://finance.yahoo.com/q/cf?s=BIIB+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BIIB
Market Watch http://www.marketwatch.com/investing/stock/BIIB
Bloomberg http://www.bloomberg.com/quote/BIIB:US
Morningstar http://quotes.morningstar.com/stock/s?t=BIIB
Bussinessweek http://investing.businessweek.com/research/st...icker=BIIB
Barchart http://www.barchart.com/quotes/stocks/BIIB
OTC Short Report http://otcshortreport.com/index.php?index=BIIB
Investopedia http://www.investopedia.com/markets/stocks/BIIB/?wa=0

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Southern Company Sparks Swift Power Restoration Post-Isaias

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

AI Drives Major Time Savings in Endoscopy Tech

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

NARUTO Card Game Set for June 2027 Global Launch

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...